1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. China >
  5. Hologic Acquires Beijing TCT Medical Technology Co.

M&A Deal Summary

Hologic Acquires Beijing TCT Medical Technology Co.

On June 1, 2011, Hologic acquired medical products company Beijing TCT Medical Technology Co. for 135M USD

Acquisition Highlights
  • This is Hologic’s 11th transaction in the Medical Products sector.
  • This is Hologic’s 13th largest (disclosed) transaction.
  • This is Hologic’s 1st transaction in China.

M&A Deal Summary
Date 2011-06-01
Target Beijing TCT Medical Technology Co.
Sector Medical Products
Buyer(s) Hologic
Deal Type Add-on Acquisition
Deal Value 135M USD

Target

Beijing TCT Medical Technology Co.

Beijing, China
Beijing TCT Medical Technology Co.,Ltd. is a high-tech medical equipment and supplies importer focusing on women health diagnosis and treatment, who enjoys over 30% of share in cervical cancer screening market in China. Company is a exclusive distributor of Cytyc Corp and successfully introduced ThinPrep cytology product into China.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Hologic

Marlborough, Massachusetts, United States
Category Company
Founded 1985
Sector Medical Products
Revenue 4.0B USD (2024)
DESCRIPTION
Hologic's corporate headquarters in Marlborough, Massachusetts.
Hologic's corporate headquarters in Marlborough, Massachusetts.

Hologic is a developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products, with an emphasis on serving the healthcare needs of women throughout the world. Hologic was formed in 1985 and is based in Marlborough, Massachusetts.

DEAL STATS #
Overall 12 of 25
Sector: Medical Products M&A 11 of 19
Type: Add-on Acquisition M&A Deals 11 of 23
Country: China M&A 1 of 1
Year: 2011 M&A 2 of 2
Size (of disclosed) 13 of 24
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-01-07 Interlace Medical

Framingham, Massachusetts, United States

Interlace Medical, Inc., is a developer and manufacturer of the MyoSure hysteroscopic tissue removal system (MyoSure).

Buy $125M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-08-01 Gen-Probe

San Diego, California, United States

Gen-Probe, Inc., is a provider in the development, manufacture and marketing of rapid, accurate and cost-effective molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility.

Buy $3.8B
Mergr

Solution for

Product

Company

Legal